Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals diagnosed with Guillain-Barré syndrome led to faster muscle strength recovery and mobility.
Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But ...
The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback